Pfizer Still Looking To Buy A Tax Advantage – And Before Congress Flips
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is willing to make a “bold” M&A move, including one that will improve the company’s tax situation, CEO Ian Read told Q3 earnings call, despite the US government’s initiatives to curb tax inversion deals.